Durham, NC, United States of America

Eric Francis Donaldson

This inventor holds 2 USPTO granted patents. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2018-2023.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eric Francis Donaldson: Innovator in Norovirus Research

Introduction

Eric Francis Donaldson is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of virology, particularly in the development of therapeutics and diagnostics for norovirus.

Latest Patents

Donaldson holds 2 patents related to norovirus research. His latest patents include "Methods and compositions for norovirus vaccines and diagnostics," which focuses on innovative methods and compositions aimed at creating effective vaccines and diagnostics for norovirus. Another significant patent is "Methods and compositions for norovirus blockade epitopes," which provides methods and compositions that involve a chimeric norovirus capsid protein. This protein comprises a norovirus VP1 major capsid protein backbone that includes various norovirus epitopes.

Career Highlights

Donaldson is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has been instrumental in advancing the understanding of norovirus and developing potential therapeutic solutions.

Collaborations

He collaborates with esteemed colleagues, including Lisa Chon Lindesmith and Ralph Baric, who are also prominent figures in the field of virology.

Conclusion

Eric Francis Donaldson's innovative work in norovirus research highlights his commitment to improving public health through scientific advancements. His contributions are paving the way for future developments in vaccine and diagnostic technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…